- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 12, 2025 | 27.11M sh |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $2.52B |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $1.51B |
| Total Assets | FY 2024 · Dec 31, 2023 | $4.02B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 28.46M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $55.33M |
| Capex | FY 2024 · Dec 31, 2022 | $9.33M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $184.07M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $17.24 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $17.60 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $214.81M |
| Net Income | FY 2024 · Dec 31, 2022 | $490.66M |
| Operating Income | FY 2024 · Dec 31, 2022 | $637.45M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2022 | $3.09B |
| Revenue | FY 2024 · Dec 31, 2022 | $4.13B |